Exendin‐4 from Heloderma suspectum venom: From discovery to its latest application as type II diabetes combatant - Yap - 2019 - Basic & Clinical Pharmacology & Toxicology - Wiley Online Library
Quantification of Exenatide Using Xevo TQD | Waters
Amino acid sequence of GLP-1 (a) and exenatide (b). | Download Scientific Diagram
Developing a novel exenatide-based incretin mimic (αB-Ex): Expression, purification and structural-functional characterization - ScienceDirect
Ultra-sensitive bioanalysis of the therapeutic peptide exenatide for accurate pharmacokinetic analyses at effective plasma concentrations utilizing UPLC-MS/MS - ScienceDirect
D-Ser32)-Exenatide | Omizzur
PDB-101: Global Health: Diabetes Mellitus: Managing: Pharmacological
Frontiers | The GLP-1 Receptor Agonist Exenatide Ameliorates Bone Composition and Tissue Material Properties in High Fat Fed Diabetic Mice
Glycosylation Improves the Proteolytic Stability of Exenatide | Bioconjugate Chemistry
Amino acid sequence of GLP-1 (a) and exenatide (b). | Download Scientific Diagram
Quantification of Exenatide Using Xevo TQD | Waters
Once weekly exenatide compared with insulin glargine titrated to target in patients with type 2 diabetes (DURATION-3): an open-label randomised trial - The Lancet
Exenatide peptide from UK based laboratory AltaBioscience
Peptide-oligourea hybrids analogue of GLP-1 with improved action in vivo | Nature Communications
Lilly's GLP-1 and Tirzepatide initiates phase III clinical trial